BACLOFEN | A214445 | RUBICON RESEARCH LTD
| Case | Court | Filed | Status | Judge |
|---|---|---|---|---|
METACEL PHARMACEUTICALS LLC v. RUBICON RESEARCH PRIVATE LIMITED 1 patentANDA 214445baclofen | D.N.J. | 2025-02-20 | Terminated 2025-05-02 | — |
| D.N.J. | 2021-10-29 | Terminated 2022-10-14 | — |
Source: PACER. NOS 835 (Patent - Abbreviated New Drug Application).
Highest NADAC/Unit
$2.17
per ml
Lowest NADAC/Unit
$1.14
per ml
Brand NDCs
0
Generic NDCs
3
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 72888046602BACLOFEN 10 MG/5 ML SOLUTION | $2.17 | ML | Generic | — | 2026-06-17 |
| 73352010316BACLOFEN 5 MG/5 ML SOLUTION | $1.14 | ML | Generic | — | 2026-06-17 |
| 72888010324BACLOFEN 5 MG/5 ML SOLUTION | $1.14 | ML | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.